ContextVision AB : ContextVision makes quantum leap in R&D
ContextVision AB (OSE: COV), the medical imaging software company, has announced that the company's Board of Directors has decided to invest aggressively into the strategic development of new technology. This represents a quantum leap in the company's R&D efforts and future business scope. The strategy will broaden ContextVision's technology platform, thereby reinforcing the company's position within its current medical image analysis and enhancement business, as well as introduce ContextVision's technology in entirely new markets. ContextVision is the world leader within its niches